Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20063307HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20035397HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20035398HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20018252HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20019409HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20019410HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20019411HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020737HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20063427HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20063428HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TCGA Plot Options
Drug Information
GeneCD274
DrugBank IDDB00313
Drug NameValproic acid
Target IDBE0003441
UniProt IDQ9NZQ7
Regulation Typedownregulator
PubMed IDs28812434
CitationsBooth L, Roberts JL, Poklepovic A, Dent P: [pemetrexed + sildenafil], via autophagy-dependent HDAC downregulation, enhances the immunotherapy response of NSCLC cells. Cancer Biol Ther. 2017 Sep 2;18(9):705-714. doi: 10.1080/15384047.2017.1362511.
GroupsApproved; Investigational
Direct ClassificationMethyl-branched fatty acids
SMILESCCCC(CCC)C(O)=O
PathwaysValproic Acid Metabolism Pathway
PharmGKBPA451846
ChEMBLCHEMBL109